Search Results
Nov 12, 2025, 10:00 ET Carolina Molecular Partners with Pixelgen, Becomes First US Certified Service Provider for Pixelgen Proxiome Kit
Pixelgen Proxiome Kit, delivers nanoscale spatial analysis of immune cell proteins at scale. The assay uses DNA-barcoded antibodies and rolling circle amplification to create a high-resolution map of protein colocalization, clustering, and abundance, providing
More news about: Pixelgen Technologies
Nov 12, 2025, 09:37 ET East Coast Wings + Grill in Clemmons, NC Announces New Ownership
shared passion for creating community-driven dining experiences. "Dafni and I both grew up in restaurants — it's truly in our DNA," said Gregory Ballas. "We love the fast-paced environment, but more than that, we love the people who make it all happen. Our goal is to create
More news about: East Coast Wings + Grill
Nov 12, 2025, 09:30 ET Pillar Biosciences Enables Rapid, Localized Tumor Profiling of Lymphoid Malignancies with Launch of New Kitted NGS Panel
The oncoReveal Lymphoid panel interrogates 84 genes of interest, including full coding DNA sequence (CDS) of 29 genes with a single-tube, fully automatable NGS workflow that can be performed by any NGS-equipped molecular laboratory.
More news about: Pillar Biosciences, Inc.
Nov 12, 2025, 09:00 ET Deltek Unveils Intelligent Platform Innovations that Elevate the Project Lifecycle
customers operate faster and more intelligently without compromising compliance or control. Built on the Deltek Native Architecture (DNA) and Dela™, Deltek's AI orchestrator,
More news about: Deltek
Nov 12, 2025, 09:00 ET Deltek Unveils Intelligent Platform Innovations that Elevate the Project Lifecycle
customers operate faster and more intelligently without compromising compliance or control. Built on the Deltek Native Architecture (DNA) and Dela™, Deltek's AI orchestrator,
More news about: Deltek
Nov 12, 2025, 09:00 ET Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Nov 12, 2025, 09:00 ET Hollywood Exec Kevin Reilly Named CEO of Kartel to Lead the New Era of Creative Intelligence
commerce, nurturing unique voices and scaling valuable brands and IP. Kartel is built to be a trusted partner for brands seeking to empower their unique DNA with AI systems and solutions at scale." Reilly has built and led some of the biggest and most successful brands in entertainment
More news about: Kartel
Nov 12, 2025, 09:00 ET DR. SABINE HAZAN WINS OUTSTANDING PRESENTATION AWARD FOR GROUNDBREAKING AUTISM AND MICROBIOME RESEARCH
Intervention: Microbiome-targeted therapy over nine months. Methodology: Fecal samples were collected at baseline, month 1, and month 9. DNA was extracted, quantified, and sequenced using ProgenaBiome's cutting-edge assay to determine microbial composition and relative abundance.
More news about: ProgenaBiome
Nov 12, 2025, 09:00 ET SEI Expands Tax Management and Overlay Capabilities
"These enhancements underscore our focus on simplifying the complex and empowering investors—and deepen our belief that tax management is part of our DNA, and not just a feature. We're setting a new standard for how modern portfolios are optimized by empowering advisors and their clients to transition
More news about: SEI Investments Company
Nov 12, 2025, 08:58 ET Market Testing Confirms Nootropics Depot Is the Only Source of Authentic Ecklonia cava
of dieckol—the key bioactive compound responsible for the seaweed's renowned health benefits. This finding, based on third-party chromatography and DNA analysis, underscores a widespread issue of mislabeling and authenticity in the supplement market.
More news about: Nootropics Depot
Nov 12, 2025, 08:00 ET Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
EsoGuard® Esophageal DNA Tests in 3Q25. Recognized $1.2 million in EsoGuard revenue for 3Q25. MolDX-participating Medicare
More news about: Lucid Diagnostics
Nov 12, 2025, 07:05 ET Epicutis Expands Global Footprint With New Offices in Sydney and Kyoto
education, and spa partnerships across Australia and New Zealand. Kyoto, Japan: Honoring the Brand's Japanese DNA Epicutis' expansion into Japan carries deep significance for the company. "Japan has played a vital role in
More news about: Epicutis Skincare
Nov 12, 2025, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
Company's class of DNA polymerase IIIC inhibitors, including composition of matter. To date, Acurx has obtained three U.S. patents, one Israeli patent, one Japanese patent, one Indian patent, and now the Australian patent, in each case, which cover the ACX-375C program, relating to DNA Pol IIIC Inhibitors
More news about: Acurx Pharmaceuticals, Inc.
Nov 12, 2025, 07:01 ET CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CM5480 restored or improved multiple disease-affected pathways and functions—including heart contraction and cardiac output, gene expression profiles, DNA repair, and metabolism. Treatment with CM5480 also significantly reduced right ventricular dysfunction (RVD) both as a monotherapy and in combination
More news about: CalciMedica, Inc.
Nov 12, 2025, 07:00 ET CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension
in animals with PAH were restored or improved. These included heart contraction and cardiac output, gene expression profiles impacted by the disease, DNA repair, and metabolic pathways. Dual therapies combining CM5480 with either ambrisentan or sildenafil yielded significantly greater benefits than the
More news about: CalciMedica, Inc.
Nov 12, 2025, 05:30 ET Best NMN Supplement (2025): California Gold Nutrition Named Leading Longevity Formula by Expert Consumers
recognized as a precursor to Nicotinamide Adenine Dinucleotide (NAD+), a coenzyme involved in energy metabolism, mitochondrial function, and DNA repair. Scientific literature indicates that NAD+ levels decline naturally with age, a process linked to decreased cellular efficiency and energy.
More news about: ExpertConsumers.org
Nov 12, 2025, 00:46 ET Advancing Innovation with Openness -- Huawei holds the 6th Innovation and IP Forum
"Open innovation drives society and technology forward, and it's in our DNA. We are committed to an open approach to innovation," said the company's Chief Legal Officer Liuping Song. "Huawei respects the IP of others, and protects
More news about: Huawei
Nov 12, 2025, 00:17 ET Advancing Innovation with Openness -- Huawei holds the 6th Innovation and IP Forum
"Open innovation drives society and technology forward, and it's in our DNA. We are committed to an open approach to innovation," said the company's Chief Legal Officer Liuping Song. "Huawei respects the IP of others, and protects
More news about: Huawei
Nov 11, 2025, 17:31 ET Antibody-Mediated Rejection Market Set to Expand Significantly During the Forecast Period (2025-2034) Amid Advances in Diagnostics and Targeted Therapies | DelveInsight
in Diagnostics and Biomarker Monitoring Improved assays (high-resolution anti-HLA/DSA testing, cell-free DNA, complement activation markers) enable earlier and more precise detection of AMR — driving uptake of monitoring services and treatment interventions,
More news about: DelveInsight Business Research, LLP
Nov 11, 2025, 16:05 ET Illumina To Webcast Upcoming Investor Conference
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Nov 11, 2025, 13:21 ET True Global Ventures två stora milstolpar i portföljen inom 72 timmar i USA
utbildning till finans och bortom — till en ännu bredare publik." Han fortsatte: "Vårt samarbete med Currenc speglar ett gemensamt DNA — båda organisationerna omformar hur värde rör sig globalt. Tillsammans strävar vi efter att påskynda övergången till öppna, interoperabla digitala ekonomier.
More news about: True Global Ventures
Nov 11, 2025, 13:00 ET KEENON Robotics odhaľuje na veľtrhu ISSA North America Expo čistiaceho robota C55 v rámci prezentácie svojho komplexného portfólia
LAS VEGAS, 11. november 2025 /PRNewswire/ – Dňa 11. novembra odhalila spoločnosť KEENON Robotics na veľtrhu ISSA North America Expo svojho profesionálneho robota C55 na zametanie a drhnutie stredných
More news about: KEENON Robotics
Nov 11, 2025, 10:13 ET Announcing the 2026 Franklin Institute Award Laureates
the Bower Award and Prize for Achievement in Science for his groundbreaking work in gene editing to correct disease-causing "misspellings" in DNA PHILADELPHIA, Nov. 11,
More news about: The Franklin Institute
Nov 11, 2025, 09:36 ET GenomOncology Partners with Glioblastoma Foundation to Accelerate Precision Glioblastoma Brain Cancer Treatment
execution—demonstrating the platform's efficiency in critical care situations. Patient samples undergo comprehensive genomic panel testing (DNA), RNA fusion panel analysis, and whole genome sequencing methylation testing for MGMT. The project goal is for GenomOncology's platform to aggregate
More news about: GenomOncology
Nov 11, 2025, 09:00 ET True Global Ventures celebrates two major portfolio milestones in 72 hours, marking a defining moment in the U.S.
education to finance and beyond — to an even broader audience." He continued: "Our collaboration with Currenc reflects shared DNA — both organizations are reinventing how value moves globally. Together, we aim to accelerate the transition toward open, interoperable digital economies.
More news about: True Global Ventures